Photo: akindo, Getty Images
A new report from New York City Health Business Leaders found that during the second quarter of 2018, investors poured more than $300 million into healthcare startups based in the Big Apple.
The investment update also provides a closer look at the 12 biggest financings of Q2.
presented by
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Thrive Global, the consumer wellness platform headed up by Arianna Huffington, was at the top of the list. In May, it announced it brought in $43 million.
Aetion, which focuses on real-world data through the science and analytics platform it provides, raised $36.4 million in April.
Patient payment platform Cedar Healthcare wasn’t far behind, securing $36 million in Q2.
Celmatix is a biotechnology company that relies on genomics and data to help women make more informed reproductive health decisions. It raised $22.5 million in the quarter.
Another startup, Vi, got $20 million in funding in June. It provides an on-demand personal trainer and fitness tracker.
Kronos Bio works in the research and development realm to create therapies for cancer. It raised $18 million in Q2.
Click Therapeutics, which makes and commercializes software as prescription medical treatments for patients, secured $17.3 million.
Founded in 2016, Owkin provides machine learning tools for medical research purposes. In May, it brought its Series A funding to $16 million.
Simple Contacts lets users renew their contact lens prescriptions directly from its app or website. It also raked in $16 million in May.
In Q2, RubiconMD raised a $13.8 million Series B round. The company has an eConsult platform that lets primary care physicians connect with specialists.
US HealthVest is a behavioral health company that landed $10 million in funding. It provides psychiatric and substance abuse services to patients of various ages.
Having raised $10 million in April, Parsley Health seeks to bring a more personalized, holistic approach to healthcare. Its goal of redefining primary care includes enabling longer patient-doctor visits.
Earlier this year, NYCHBL also put out a report on New York City’s health tech and life science investment landscape. Written by NYCHBL president and co-founder Bunny Ellerin and Columbia Business School MBA student Daniyal Hussain, it noted that life science and health tech accounted for $13.8 billion across 412 deals across the country in 2017. In New York City, 79 startups and growth stage companies received $703 million last year.
